| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/03/2003 | WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells |
| 07/03/2003 | WO2003053334A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/03/2003 | WO2003053292A1 Vaginal delivery of drugs |
| 07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | WO2003053163A2 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof |
| 07/03/2003 | WO2002079147B1 Inhibitors of prenyl-protein transferase |
| 07/03/2003 | WO2002076497A3 Method and composition |
| 07/03/2003 | WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins |
| 07/03/2003 | WO2002018389A3 Thienopyrimidine |
| 07/03/2003 | US20030125559 Methods for synthesizing ether compounds and intermediates therefor |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125335 Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125319 Administering an estrogen agonist/ antagonist while reducing the side effects associated with estrogen administration; urinary and vaginal infections; incontinence; vaginal dryness; kits for assessing vaginal health |
| 07/03/2003 | US20030125299 Method for treating or preventing inflammatory diseases |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents |
| 07/03/2003 | US20030124193 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 07/03/2003 | US20030124179 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 07/03/2003 | US20030124150 Kit for reducing aching |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | CA2849201A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2471400A1 Vaginal delivery of drugs |
| 07/03/2003 | CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 07/03/2003 | CA2471096A1 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 07/03/2003 | CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | CA2471085A1 Aroyl pyridinones |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/03/2003 | CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469370A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2469042A1 Triazoles as oxytocin antagonists |
| 07/02/2003 | EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 07/02/2003 | EP1323433A1 Compositions for preventing urinary calculus |
| 07/02/2003 | EP1323429A1 Preventives/remedies for emotional disorders |
| 07/02/2003 | EP1323421A1 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322663A1 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5- g(a)-androst-1-en-3-one and a process for preparing it |
| 07/02/2003 | EP1322645A2 Quinazolines, medicaments, which contain these compounds and which are effective as tyrosine kinase inhibitors, their use, and methods for the production thereof |
| 07/02/2003 | EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322596A1 Zwitterionic tachykinin receptor antagonists |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1322286A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/02/2003 | EP1224180B1 Substituted azoles |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP0954292B1 Pharmaceutical formulations with delayed drug release |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments |
| 07/02/2003 | CN1427825A Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 07/02/2003 | CN1427716A Carbohydrate medical solution and sulphite stabilisator in multiple compartment container and use thereof |
| 07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
| 07/02/2003 | CN1112928C Use of CGMP-phosphodiesterase inhibitors to treat impotence |
| 07/01/2003 | US6586623 Thiol-based NAALADase inhibitors |
| 07/01/2003 | US6586474 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/01/2003 | US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea |
| 07/01/2003 | US6586442 Benzofurane derivatives, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586436 Serotonergic agents |
| 07/01/2003 | US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine |
| 07/01/2003 | US6586402 Leucine replaced by neopentylglycine or adamantylalanine |
| 07/01/2003 | US6586179 Human Eag2 |
| 07/01/2003 | US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes |
| 07/01/2003 | US6585995 Administering to a subject to inhibit a vaso-occlusive event an agent that reduces platelet counts in the subject in an amount effective to reduce platelet count in the subject to at least a low normal level |
| 06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
| 06/26/2003 | WO2003051903A1 Androstane derivative having substituent in 7- and 17-positions |
| 06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 06/26/2003 | WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof |
| 06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
| 06/26/2003 | WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 06/26/2003 | WO2003051868A1 Lactams as tachykinin antagonists |
| 06/26/2003 | WO2003051866A1 2-guanidino-4-heterocyclylquinazolines |
| 06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
| 06/26/2003 | WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 06/26/2003 | WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 06/26/2003 | WO2003051825A1 Human adam-10 inhibitors |
| 06/26/2003 | WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 06/26/2003 | WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents |
| 06/26/2003 | WO2003051393A2 Enzymatic cleavable reagents for specific delivery to disease sites |
| 06/26/2003 | WO2003051377A1 Method for preparing fetuin and polypeptide to induce apoptosis |
| 06/26/2003 | WO2003051372A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
| 06/26/2003 | WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/26/2003 | WO2003051354A1 Method of treatment |
| 06/26/2003 | WO2003051353A1 Substituted beta-aminoalcohols used as medicaments |
| 06/26/2003 | WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |